Millennium Management
GALTW

Millennium Management’s Galectin Therapeutics Inc. - Warrants GALTW Stock Holding History

Millennium Management’s Portfolio GALTW Stock Details GALTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-640,800
Closed -$35K – 4144
2016
Q4 		$35K Hold
640,800
– – ﹤0.01% 3267
2016
Q3 		$101K Buy
+640,800
New +$226K ﹤0.01% 3133

Millennium Management's GALTW Position: Q1 2017 in Review

Millennium Management sold out of Galectin Therapeutics Inc. - Warrants (GALTW) in Q1 2017, closing a stake of 640,800 shares — an estimated $35K sold.

Millennium Management first reported a position in GALTW in Q3 2016 and held it in 2 quarters. The position peaked at $101K in Q3 2016. 0 funds tracked by Wall St. Rank hold GALTW as of Q1 2017.

  • Millennium Management reported no remaining Galectin Therapeutics Inc. - Warrants position as of Q1 2017 after selling out during the quarter.
  • Millennium Management sold 640,800 Galectin Therapeutics Inc. - Warrants shares in Q1 2017, an estimated $35K.
  • Millennium Management first reported a position in Galectin Therapeutics Inc. - Warrants in Q3 2016 and held it in 2 quarters.
  • Millennium Management's Galectin Therapeutics Inc. - Warrants position peaked at $101K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Galectin Therapeutics Inc. - Warrants as of Q1 2017.

Based on Millennium Management's 13F filing for Q1 2017, filed 15 May 2017.